Paul H. Sugarbaker, MD; Marcello Deraco, MD; Olivier Glehen, MD; Cyril William Helm, MD; David L. Morris, MD; Kurt Van der Speeten, MD
This second edition on a new approach combining cytoreductive surgery with perioperative chemotherapy to treat peritoneal metastases offers hope for long-term survival in these patients. This text includes major updates on both ovarian malignancy and malignant peritoneal mesothelioma. The book also features emphasis on presentation of clinical trials recently reported or in progress as well as expanded applications of CRS and HIPEC for unusual diseases that show isolated peritoneal metastases. HIPEC regimen has been collected and critically evaluated for global application and added to this second edition for reference. Surgical video presentations accompany the text.
"This well-written book will definitely contribute to increasing the awareness of this highly aggressive treatment, and ultimately, optimize the outcomes."
Ms. Lene Hjerrild Iversen, DMSci, PhD
Professor Søren Laurberg, DMSci
Aarhus University Hospital